Table 3.
Cutoff value | AUC | 95% Confidence interval | Sensitivity (%) | Specificity (%) | |||
---|---|---|---|---|---|---|---|
Single parameter | |||||||
US | |||||||
TCT | ≥4 mm | 0.964 | 0.779-1.000 | 100 | 90.9 | ||
Cyst size | ≤2.8 cm | 0.886 | 0.673-0.982 | 80 | 81.8 | ||
GB mucosal irregularity | 100 | 100 | |||||
MRI | |||||||
TCT | ≥4 mm | 0.936 | 0.739-0.996 | 90 | 81.8 | ||
Cyst size | ≤2.2 cm | 0.900 | 0.690-0.987 | 70 | 100 | ||
Invisible CBD | 100 | 100 | |||||
Combined parameters | |||||||
US | |||||||
TCT+GB mucosal irregularity | - | 1.000 | - | - | - | ||
Cyst size+GB mucosal irregularity | - | 1.000 | - | - | - | ||
MRI | |||||||
TCT+invisible CBD | - | 1.000 | - | - | - | ||
Cyst size+invisible CBD | - | 1.000 | - | - | - |
AUC, area under the curve; US, ultrasonography; TCT, triangular cord thickness; GB, gall bladder; MRI, magnetic resonance imaging; CBD, common bile duct.